Trials / Sponsors / Alder Biopharmaceuticals, Inc.
Alder Biopharmaceuticals, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | An Open Label Trial of ALD403 (Eptinezumab) in Chronic Migraine Migraine Disorder | Phase 3 | 2016-12-01 |
| Completed | Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine Migraine Disorders | Phase 3 | 2016-11-01 |
| Completed | A Multicenter Assessment of ALD403 in Frequent Episodic Migraine Migraine Disorders | Phase 3 | 2015-09-01 |
| Completed | A Multicenter Assessment of ALD403 in Chronic Migraine Migraine Disorders | Phase 2 | 2014-10-01 |
| Completed | Safety, Efficacy and Pharmacokinetics of ALD403 Migraine | Phase 1 | 2013-01-01 |
| Completed | Safety Tolerability and Pharmacokinetics of ALD403 Migraine Disorders | Phase 1 | 2012-04-01 |